PUBLISHER: The Business Research Company | PRODUCT CODE: 1948642
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948642
Wearable cardiac devices are electronic medical tools that continuously track heart activity, including heart rate and rhythm, through built-in sensors. These devices can identify irregular heartbeats and, in certain cases, automatically deliver therapeutic electrical shocks to restore normal rhythm in patients at risk of sudden cardiac arrest.
The primary types of wearable cardiac devices include Holter monitors, smartwatches, patches, defibrillators, pulse oximeters, and other related products. A Holter monitor is a compact, wearable device that records heart activity continuously for 24-48 hours to detect irregular rhythms during everyday activities. These devices serve multiple purposes such as arrhythmia detection, heart rate monitoring, and managing heart diseases. They are distributed via both online and offline channels and are used by a range of end users including hospitals, clinics, individual consumers, and fitness centers.
Tariffs are impacting the wearable cardiac devices market by raising the cost of imported electronic components, sensors, and manufacturing equipment, resulting in increased production costs for device manufacturers. Segments such as smartwatches, wearable defibrillators, and advanced ECG-enabled patches are most affected, particularly in regions like Asia-Pacific and North America, which rely heavily on cross-border component supply chains. While tariffs create pricing pressures, they also incentivize local manufacturing, encourage regional innovation, and support the development of cost-optimized devices for domestic and global markets.
The wearable cardiac devices market research report is one of a series of new reports from The Business Research Company that provides wearable cardiac devices market statistics, including wearable cardiac devices industry global market size, regional shares, competitors with a wearable cardiac devices market share, detailed wearable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable cardiac devices industry. This wearable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wearable cardiac devices market size has grown rapidly in recent years. It will grow from $5.65 billion in 2025 to $6.73 billion in 2026 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to limited availability of advanced cardiac monitoring technology, rising incidence of cardiovascular diseases, dependence on hospital-based monitoring, high cost of early wearable devices, lack of consumer awareness about wearable cardiac devices.
The wearable cardiac devices market size is expected to see rapid growth in the next few years. It will grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to miniaturization of sensors and devices, increasing adoption of remote patient monitoring solutions, integration with smartphones and digital health platforms, rising health consciousness among consumers, expansion of reimbursement policies for wearable cardiac devices. Major trends in the forecast period include growing adoption of wearable cardiac devices for remote patient monitoring, increasing integration of ecg and heart rate monitoring features, rising use of wearable defibrillators for sudden cardiac arrest prevention, expansion of consumer-focused fitness and wellness devices, development of wireless and disposable cardiac monitoring patches.
The rising incidence of cardiovascular diseases is anticipated to drive the expansion of the wearable cardiac devices market in the coming years. Modifiable risk factors for cardiovascular disease include high blood pressure, unhealthy dietary habits, increased LDL cholesterol levels, lack of physical activity, and certain environmental exposures, all of which contribute to conditions such as coronary artery disease, heart failure, stroke, and hypertension. Wearable cardiac devices play an important role in public health by enabling continuous, real-time monitoring of cardiac activity, supporting early identification and management of these risk factors, and reducing the likelihood of severe cardiovascular events through ongoing tracking of key parameters such as heart rate, cardiac rhythm, and electrical signals. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023 cardiovascular disease was responsible for 919,032 deaths, representing nearly one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and notably, approximately one in six cardiovascular-related deaths occurred among adults under the age of 65. As a result, the growing prevalence of cardiovascular diseases is contributing significantly to the growth of the wearable cardiac devices market.
Leading companies in the wearable cardiac device market are increasingly concentrating on the development of advanced offerings, including extended-wear, AI-enabled ECG patches, to support continuous remote heart monitoring, enable early identification of arrhythmias, and promote home-based cardiac care. These extended-wear AI-enabled ECG patches are slim, flexible adhesive devices applied to the chest that continuously capture the heart's electrical signals over several days (such as up to two weeks) and use integrated biosensors combined with AI-powered analytics to identify arrhythmias more effectively than conventional Holter monitors. For example, in September 2023, iRhythm Technologies, a U.S.-based digital health company, introduced its next-generation Zio monitor, described as the smallest, lightest, and thinnest cardiac patch monitor within its Zio long-term continuous monitoring (LTCM) service. The Zio monitor enables up to 14 days of uninterrupted ECG monitoring, incorporates a breathable and waterproof design with hydrocolloid adhesive, and integrates with iRhythm's ZEUS AI software to improve arrhythmia detection efficiency, thereby enhancing patient comfort and increasing diagnostic accuracy.
In May 2024, WearLinq Inc., a US-based digital health firm specializing in wearable cardiac technology, acquired AMI Cardiac Monitoring LLC for an undisclosed price. Through this acquisition, WearLinq aimed to expand its clinical services across the US by combining AMI's diagnostic expertise with its FDA 510(k)-cleared 6-lead ECG wearable device. AMI Cardiac Monitoring LLC is a US-based company known for offering the WearLinq eWave, a wireless 6-lead cardiac monitor designed to provide both patient comfort and clinical accuracy.
Major companies operating in the wearable cardiac devices market are Apple Inc., Samsung Electronics Co. Ltd., Abbott Laboratories, Medtronic plc, Garmin Ltd., Masimo Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Biofourmis, Bittium Corporation, BPL Medical Technologies Pvt. Ltd., NeuroSky Inc., Bionet Co. Ltd., AliveCor Inc., Qardio Inc., Empatica Inc., VitalConnect Inc., Lifesignals Group, Biotricity Inc., Shimmer Research
North America was the largest region in the wearable cardiac devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable cardiac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the wearable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The wearable cardiac devices market consists of sales of insertable cardiac monitors (ICMS), wearable ECG t-shirts, smart garments, chest strap ECG monitors, continuous blood pressure monitors, wearable telemetry devices, smart rings, ECG-enabled hearing aids, and ECG-enabled earbuds. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wearable Cardiac Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses wearable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for wearable cardiac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable cardiac devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.